.FDA refuses psychedelic MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Permit MDMA Treatment, Looking For Even More Research Study The Nyc TimesFDA Rejects Ecstasy-Based Medication The Commercial JournalFDA refuses to permit unfamiliar MDMA treatment to deal with post-traumatic stress disorder, with request for additional trial data CNNFDA turns down to begin with psychedelic to alleviate PTSD, calling for even more research study The Washington Post.